866
Registered trials
329
Recruiting
491
Completed trials
274
Sponsors active
159
Research sites
Phase III:
526
Phase II/III:
44
Phase II:
127
Phase I/II:
16
Phase III/IV:
11
Phase IV:
21
Phase I:
13
Phase I (Other):
30
Phase I (FiH):
12
Other:
66
Oversight events in trials active here:
49 serious breaches
249 temporary halts
25 urgent safety measures
33 unexpected events
45 corrective measures
across 140 trials
View oversight register →
Top conditions
Non-small cell lung cancer
31
Pulmonary arterial hypertension
12
Multiple sclerosis
12
Crohn's disease
11
HER2 positive breast cancer
10
Systemic lupus erythematosus
9
Breast cancer
9
Hormone receptor positive HER2 negative breast cancer
9
Non-small cell lung cancer metastatic
7
Dermatitis atopic
7
Rheumatoid arthritis
6
Squamous cell carcinoma of head and neck
6
Top sponsors
Novartis Pharma AG
44
Merck Sharp & Dohme LLC
42
Janssen - Cilag International
39
F. Hoffmann-La Roche AG
37
AbbVie Deutschland GmbH & Co. KG
36
Amgen Inc.
29
AstraZeneca AB
29
Sanofi-Aventis Recherche & Developpement
24
Boehringer Ingelheim International GmbH
23
Novo Nordisk A/S
22
Boehringer Ingelheim Espana S.A.
20
Bluepharma Industria Farmaceutica S.A.
17
Cities with most trials
All 49 cities →All trials — page 31
866 totalShowing 721–744 of 866 trials